1-Chloroethyl chloroformate → HCID 66975154, compound
Reaction equation
C([N:8]1[CH2:14][CH:13]([C:15]2[CH:20]=[CH:19][C:18]([Cl:21])=[C:17]([Cl:22])[CH:16]=2)[CH:12]([CH2:23][O:24][Si](C(C)(C)C)(C)C)[O:11][CH2:10][CH2:9]1)C1C=CC=CC=1.ClC(OC(Cl)C)=O>C(#N)C>[ClH:21].[Cl:22][C:17]1[CH:16]=[C:15]([CH:13]2[CH:12]([CH2:23][OH:24])[O:11][CH2:10][CH2:9][NH:8][CH2:14]2)[CH:20]=[CH:19][C:18]=1[Cl:21]Participants
4
Reactant 2
Product 1
Reagents, catalysts & solvents 1
Procedure
To a solution of (6RS,7SR)-4-benzyl-7-({[tert-butyl(dimethyl)silyl]oxy}methyl)-6-(3,4-dichlorophenyl)-1,4-oxazepane (250 mg) in acetonitrile (1.5 mL) was added 1-chloroethyl chloroformate (0.0786 mL), and the mixture was stirred at room temperature for 1.5 hr. The solvent was evaporated under reduced pressure. To the residue was added methanol (1.5 ml), and the reaction mixture was stirred at 60° C. for 3 hr. The solvent was evaporated under reduced pressure. The residue was solidified with diisopropyl ether, and the obtained crude crystals were recrystallized from ethanol/ether/water to give the title compound (76.8 mg).
Workup
- customThe solvent was evaporated under reduced pressure
- additionTo the residue was added methanol (1.5 ml)
- stirringthe reaction mixture was stirred at 60° C. for 3 hr
- customThe solvent was evaporated under reduced pressure
- customthe obtained crude crystals
- customwere recrystallized from ethanol/ether/water
Sources & evidence
- ORD record
- ord-5df39f6e2bf54533b2102a212fabd748
- Source dataset
- uspto-grants-2014_05
- Patent number
- US08722662B2
Reaction notes
Loading…